Error message

  • Warning: "continue" targeting switch is equivalent to "break". Did you mean to use "continue 2"? in include_once() (line 1374 of /kunden/351322_8001/web/5014064/A5014064/
  • Deprecated function: The each() function is deprecated. This message will be suppressed on further calls in menu_set_active_trail() (line 2405 of /kunden/351322_8001/web/5014064/A5014064/

Board of Directors

Georges Bau (Chairman)

Mr. Bau is the founder or co-founder of four medical device companies and has more than 30 years experience in the management of medical device companies with significant accomplishments in new product development, marketing and sales, regulatory and reimbursement. He first founded Advanced Biomedical Supply (ABS) in 1984 that pioneered the distribution of digital equipment and sophisticated urological implants in France. Advanced Biomedical Supply’s successes lead to its acquisition by Medtronic in 1996. In 1992, he co-founded Prince Medical, a major manufacturer of disposable medical devices currently employing more than 450 employees. In 1994, he founded Aprime Switzerland as an attempt to export the business model of a high-tech distribution company out of France. Aprime CH was sold to the management a few years later. Finally, in 1996, he started Advanced Biomedical Systems (ABS) that was aquired by The  Werfen Group (Barcelona, Spain) in 2001 and merged it with Bolton Medical to create ABS-Bolton Medical. He is now a board member, a consultant and/or a private investor in several start-up companies.

Patrick Coulombier (CEO)

PATRICK COULOMBIER, former chief operating officer of CARMAT, has headed the project team for the CARMAT bioprosthetic artificial heart within the Airbus Group since July 2001. Before that he worked for MBDA France as director of two international programs in the area of defense, one concerning a British air combat training system and the other relating to a Franco-German drone system. Between 1978 and 1990, before joining MBDA France, Patrick Coulombier had a number of diff erent research and development posts in connection with a range of aeronautic and space projects at Thales Avionique (Airbus A130, A320, Rafale Combat Aircraft, Super Puma Helicopter and the Hermes Spacecraft). Patrick Coulombier has a degree in electronic engineering.

 Pr Pierre Costa


Pierre Costa is the head of the Department of Urology at the Centre Hospitalier Caremeau in Nimes since 1996. He obtained his medical degree from the Medical  Faculty  of Medicine and then attended the University of Montpellier where he obtained his PhD in 1993. In 1994, he became Director of Research at the University of Montpellier and in 1995 became Professor of Urology. He is a member of several Urological Associations. His clinical and research interests are in the fields of urinary disorders and andrology. He is an active researcher, has conducted many lectures and has published numerous medical articles.

Pr Daniel Hayoz
Prof. Dr. Daniel Hayoz is a Founder, and professor of Vascular Medicine at the Lausanne University Hospital (CHUV), Switzerland and Head of Medicine at the Cantonal Hospital of Fribourg (Switzerland), president of the Swiss Society of Vascular Diseases, former president of the Swiss Society of Angiology and vice president of the European Society for Clinical Investigations. Prof. Hayoz has published more than 200 peer-review scientific papers and has developed a portable mini pump for the prevention of deep venous thrombosis. His experience and position is fundamental in maintaining ongoing public relations with key opinion leaders.


Dr Philippe Pouletty, MD

Dr Philippe Pouletty (MD) is co-founder and general partner of Truffle Capital. He is a renowned Biotech and Medtech industry veteran with dual experience in Silicon Valley and in France. He is founder and chairman of Deinove (ALDEI), co-founder and board member of Carmat (ALCAR), former chairman and board member of Neovacs (ALNEV), chairman of BMD and Splicos, co-founder and board member of Pharnext, Plasmaprime, Vexim, Wittycell, and board member of Immune Targeting Systems, Myopowers, Symetis, and Theraclion, all Truffle Capital portfolio companies. He is also an independent board member of Innate Pharma (Euronext). He founded SangStat (organ transplantation therapeutics) in 1988, did an IPO on NASDAQ in 1993 and sold it to Genzyme for €600m in 2002. He also founded ConjuChem in 1993 and did an IPO on the Toronto Stock Exchange in 2000. He is former chairman (2001-2009) and honorary chairman of France Biotech, the French biotech industry association and former vice chairman of EuropaBio, the European Association for Bioindustries. He is the inventor of 29 patents including the second highest revenue generating life science patent for Stanford University. He has an MD from the University of Paris VI, MS degrees in immunology and virology from Pasteur Institute, was a post-doctoral research fellow at Stanford University and became a laureate of the American Liver Foundation in 1999. He has been awarded the Chevalier de la Légion d’Honneur.